Filing Flows › Madrigal Pharmaceuticals (MDGL) › Recalls, complaints & regulation
Madrigal Pharmaceuticals (MDGL): clinical trials
Madrigal Pharmaceuticals (MDGL) beyond its filings: 8 active clinical trials.
Madrigal Pharmaceuticals' latest quarter
Madrigal Pharmaceuticals, Q3 2026: revenue $431M (+50% year over year), operating margin 13.0%, net earnings $55.4M, operating cash flow $121M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Madrigal Pharmaceuticals have?
8 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.